Pharmacological
Research Communications,
357
Vol. 4, No. 4. 1972
EFFECTS OF MONOAMINO OXIDASE INHIBITORS
ON SHUTTLE-BOX AVOIDAN-
CE BEHAVIOUR OF HAMSTERS. Mario Laboratory 1, via
of
Reno,
Received
00198
Rome,
1972
behaviour
Recently
overcome
by administration
(Sansone
and Renzi,
that
shuttle-box
ce training automated 24x21 (two tments
to
hamsters
played
and the
in
by brain
utility
of
evidentiate
test in
observed
responding of
1970,
the cate-
shuttlea psychosti-
evidentiate
the
present
antidepressant
the
low
findings
of
can be
of
suggest
hamsters
could
psychostimulant
action
research,
we have
studied
monoamine
oxidase
inhibitors,
iproniazid,
levels
or methylphenidate
The above behaviour
the
by hamsters
amphetamine
1971).
to
that
exhibited
avoidance
derivative,
METHODS
role
hamsters
we have
avoidance
tranylcypromine
the
of
and tra-
drugs.
shuttle-box
two
of
iproniazid
responding
behaviour
of
Thus,
inhibitors,
avoidance
INTRODUCTION
idrazine
Italy
confirm
in
a suitable
Renzi
The results
action
of
C.N.R.
avoidance
avoidance
fects
and Psychopharmacology,
, improved
cholamines
drugs.
Messeri
oxidase
shuttle-box.
the
and Patrizia
Two monoamine
nylcypromine
mulant
Paolo
Psychobiology
26 October
SUMMARY
-box
Sansone,
and a non
idrazine
the
be of efan
compound,
.
The technique of
hamsters
shuttle-boxes
cm compartments,
was the
same previously
(Sansone were
taken,
connected
10 W lamps)
was switched
and used
as conditioned
and Renzi, each
used 1970,
1971).
one divided
by a 7x7 cm opening. on alternately stimulus
in (CS).
for
the
into
avoidan. Eight two
A light two
compar-
The CS preceded
Pharmacological
358
the
onset
verlapped
of
the
unconditioned
it
for
45 sec.
discontinuously through
(0.5
a selenium
avoided
the
within
15 set
after
was 60 sec.
randomly
dance
(2.0 at
the
All
dose
promine
in
sion.
Table
five
50-trial
of
floor
was recorded
when the
dark
compartment
CS. The intertrial were
subjected
in
inter-
punished
and recor-
in
other
respectively. before
of
of
the
in
six
hamsters
improvement
very the
levels
of
in
experimental confirm
1971).
as sessions
second
expresses-
blocks
the
last
experimental
of
week). previous by low
acquisition
1970,
in
are
SO-trial
characterized
slowly only
groups
intraperito-
each
group
and Renzi,
in
dose
groups
avoidance
was evident
performance
each
are
shuttle-box
increased
the
for
control
saline
three
avoidances
for
avoi-
sessions.
avoidances
block
eight
and tranylcy-
experimental
mean percent
fact,
in
respectively,
ten
of
of
phosphate
the
were
SO-trial
administration
were
75
Friday).
injected
the
Sansone
to
Drugs
saline
that
daily
at
of
(one the
ten
consisting
two groups
each
1968;
the
the
between
The animals
group
Monday
iproniazid
the
weighing
to
20 and 40 mg/kg,
performance
in
each
consisted
sessions
However
grid
a 500.000
experiment.
(from
1 reports
and a sharp sion.
the
1 as mean percent
curve,
the
applied
through
hamsters
two weeks
10,
ka and Bunnel, ning
to
the
crossings
were
indicating
findings,
and o-
shock
V delivered
the
groups,
of
Performances
vels
six
one group,
hours
Fig.
off)
into of
of
Performances
RESULTS sed in
onset
in
5 and 10 mg/kg, four
(US) by 15 set
response
48 golden
to
sulfate
neally
set
(250
beginning
treatment
ml/kg) the
the
groups
sessions
Drug
1.5
US by running
were
assigned
subjects.
on,
Vol. 4, No. 4. 1972
responses.
The subjects and 95 g at
set
Spontaneous
ded as intertrial
Communications,
The US was an electric
A conditioned
animal
val
stimulus
rectifier
ohms resistance).
Research
le-
(Matal-
The learproceeded (10th)
ses-
week was
Pharmacological
Research Communications,
359
Vol. 4. No. 4. 1972
O1
2
3
4
,
t
1
I
I
5
0
7
8
9
1
10
SESSIONS
Fig.
1 - Mean percent avoidances in each of the ten daily SO-trial sessions. The experiment was carried out in two weeks, from Monday to Friday. C = control group (saline) ; IPZ 10, IPZ 20 and IPZ 40 = iproniazid phosphate at the doses of 10, 20 and 40 mg/kg respectively; TNP 5 and TNP 10 = tranylcypromine sulfate at the doses of 5 and 10 mg/kg respectively.
significantly
higher
The low
level
absence
of
at
of
to
responding
responses,
the
first
was not
which
on the
week
(Table
accompanied
contrary
were
1). by
always
a 100% level.
fective
at
proved dose
the
the
effects
dose
performances of
in
the
provements ble
comparison
avoidance
escape
As concerns
ly
in
1).
in
20 mg/kg, second
level
in
appeared
of
MAO inhibitors,
10 mg/kg,
comparison
fact,
week.
of
At
more
to
increased the evident
dose
iproniazid
while the
at
saline
avoidance level
of
higher
was inefdoses
control
group.
responding, 40 mg/kg
and statistically
im-
especial
avoidance significant
The
im(Ta-
360
Pharmacological
Research Communications,
Vol. 4. NO. 4, 1972
Mean percent avoidances (2 S.E.) in blocks of five SO-trial sessions. Significances betwegn drug and saline treatments were bssea on the Student t- test. IPZ = iproniazid
phosphate;
TNP = tranylcypromine
SESSIONS 1-5 Avoidances P Saline
6.8
-+ 1.8
IPZ
7.8
10 mg/kg
sulfate
SESSIONS 6-10 Avoidances P 28.7
-+ 6.8
-
)O.OS
23.4
)O.OS
>o.os
42.0
-+ 5.0 -+ 7.4
11 20 w/kg
14.0
-+ 2.0 + 3.7
40 w/kg
20.5
+ 2.8
(0.01
60.1
_+_3.4
5 mg/kg
17.1
+ 3.3
(0.05
47.3
10 mg/kg
28.6
+ 4.5
(0.001
67.2
-+ 4.1 + 4.9
TNP ”
x Differences significant xxP(O.05 for
between the two S-session in all groups. the ninth session.
Tranylcypromine the
dose
dance effect Table
level
of
responding was more
the
more
effective
drug
improved
comparison
evident
at
to
the
the
dose
were
of
statistically
iproniazid.
At
significantly
control level
(0.001
group.
of
avoiSuch an
10 mg/kg
(Fig.
1,
the
con-
1).
group,
(3-8%),
5 mg/kg in
Intertrial trol
appeared
blocks
;O.OSxx
but
DISCUSSION
under
responses, were
present
seldom
at
appeared
The facilitation
and tranylcypromine of
particular
interest
of
previous
researches
drug
treatments
some extent in
the
in
other
of
avoidance
observed
in
the
if
considered
concerning
the
the
first
two
sessions
sessions. responding
present in
as in
experiment,
comparison
effects
by iproniazid
of
with
appears the
MAO inhibitors
results
Pharmacological
Research Communications,
on avoidance avoidance
behaviour.
was depressed and Boff,
1960;
responding
has
(Moore
was instead
and Boff,
1971).
A facilitating
prolonged
activity
lower of
cating
the
that
fact,
brain
of the
behaviour
of
two
(Pletscher,
vious
data
Fuxe
Carlsson,
1963;
Finally,
that tle-box
can be explained is
the in 1967;
Seiden
a psychostimulant avoidance
of
the
the
two
and Herr,
to
the
of
subjected
behnviour
and Rech,
and Peterson
1967;
induced
can be easily of
indi-
1960).
on avoidance content
of
inhibition
catecholamines been
the
iproniazid
play
suggmsted
and Hanson,
experiment
action
in
findings
increased
has
at
Seiden
1966;
and
by iproniazid
support
the
evidentiated
an
by pre
1968).
improvements present
hamsters
and Erickson,
oxidase
brain
of
of
drugs
literature(Corrodi
Moore
behaviour
(Green
monoamine
levels
avoidance
effective
oxidase
by the the
or
alone
a difference
by the
much more
can be ascribed
That
given
in mice
Such
of
drugs
the
only
iproniazid.
produced
in
Voith
those
performance
tranylcypromine
1964;
1971)
on avoidance were
responding
hamsters
and Hanson,
and Herr,
avoidance
effect
reported
(Heise
improved
facilitating
in
tetrabenazine
(Oliverio,‘1967).
monoamine
role
behaviour
No effect
was observed
on
when avoidance
Voith
and Boff,
brain
1966).
MAO inhibitors
when MAO inhibitors
sessions
of
monoamines
important
1967).
tranylcypromine
as inhibitor In
and Rech,
effect
Tranylcypromine levels
1964;
Scheckel
avoidance
of
evidentiate
and Boff,
found
1960;
an effect
(Orsingher,l961),
Scheckel
(Heise
dose
been
by reserpine
c(-methyltyrosine
to
Generally
responding
361
Vol. 4. No. 4, 1972
and
assumption on shut-
hamsters.
REFERENCES Corrodi H. and Hanson L.C.F., Psychopharmacologia 10, 116-125, 1966, Fuxe K. and Hanson L.C.F., Psychopharmacologia 11, 439-447, 1967. Green H. and Erickson W., J. Pharmacol. exp. Ther. 129, 237-242, 1960.
362
Pharmacological
Research Communications,
Vol. 4. No, 4, 1972
Heise G.A. and Boff E., J. Pharmacol. exp. Ther., 129, 155-162, 1960. Matalka E.S. and Bunnel B.N., Psychon. Sci. 12, 27-28, 1968. Moore K.E. and Rech R.H., J. Pharmacol. exp. Ther., 156, 70-75, 1967. Oliverio A., 11 Farmaco (Ed. Sci.) 22, 159-171, 1967. Orsingher O.A.,Psychopharmacologia 2, 326-333, 1961. Pletscher A., Pharmacol. Rev. 18, 121-129, 1966 Sansone M. and Renzi P., Pharmacol. Res. Comm. 2, 355-360, 1970. Sansone M. and Renzi P., Pharmacol. Res. Comm. 3, 113-119, 1971. Scheckel C.L. and Boff E., Psychopharmacologia 5, 198-208,.1964. Seiden L.S. and Carlsson A., Psychopharmacologia 4, 418-423, 1963 Seiden L.S. and Peterson D.D., J. Pharmacol. exp. Ther. 159, 422-428, 1968. 20, 253-265, 1971. Voith K. and Herr F., Psychopharmacologia